HBeAg testing is better than quantitative HBsAg assay as an alternative to HBV DNA assay among HBV-infected pregnant women
Introduction: Using tenofovir disoproxil fumarate (TDF) is recommended in the 3rd trimester for pregnant women with HBV DNA ≥ 200,000 IU/mL to prevent mother-to-child transmission (MTCT) of hepatitis B virus (HBV). However, HBV DNA quantification is unavailable in many resource-limited areas worldw...
保存先:
| 主要な著者: | , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
The Journal of Infection in Developing Countries
2023-10-01
|
| シリーズ: | Journal of Infection in Developing Countries |
| 主題: | |
| オンライン･アクセス: | https://jidc.org/index.php/journal/article/view/17516 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|